Literature DB >> 9915952

Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.

L J Andrew1, V Brancolini, L S de la Pena, M Devoto, F Caeiro, R Marchegiani, A Reginato, A Gaucher, P Netter, P Gillet, D Loeuille, D J Prockop, A Carr, B F Wordsworth, M Lathrop, S Butcher, E Considine, K Everts, A Nicod, S Walsh, C J Williams.   

Abstract

Familial calcium pyrophosphate dihydrate deposition disease (CPPDD) is a disease of articular cartilage that is radiographically characterized by chondrocalcinosis due to the deposition of calcium-containing crystals in affected joints. We have documented the disease in an Argentinean kindred of northern Italian ancestry and in a French kindred from the Alsace region. Both families presented with a common phenotype including early age at onset and deposition of crystals of calcium pyrophosphate dihydrate in a similar pattern of affected joints. Affected family members were karyotypically normal. Linkage to the short arm of chromosome 5 was observed, consistent with a previous report of linkage of the CPPDD phenotype in a large British kindred to the 5p15 region. However, recombinants in the Argentinean kindred have enabled us to designate a region<1 cM in length between the markers D5S416 and D5S2114 as the CPPDD locus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9915952      PMCID: PMC1377711          DOI: 10.1086/302186

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  36 in total

1.  CHONDROCALCINOSIS (PSEUDOGOUT SYNDROME). A FAMILY STUDY.

Authors:  R W MOSKOWITZ; D KATZ
Journal:  JAMA       Date:  1964-06-08       Impact factor: 56.272

2.  [DIFFUSE FAMILIAL ARTICULAR CHONDROCALCINOSIS].

Authors:  P LOUYOT; J PETERSCHMITT; P BERTHELME
Journal:  Rev Rhum Mal Osteoartic       Date:  1964-11

3.  Identification of urate crystals in gouty synovial fluid.

Authors:  D J MCCARTY; J L HOLLANDER
Journal:  Ann Intern Med       Date:  1961-03       Impact factor: 25.391

4.  Familial chondrocalcinosis in the Chiloe Islands, Chile.

Authors:  A J Reginato; J L Hollander; V Martinez; F Valenzuela; V Schiapachasse; E Covarrubias; S Jacobelli; R Arinoviche; D Silcox; F Ruiz
Journal:  Ann Rheum Dis       Date:  1975-06       Impact factor: 19.103

5.  Mapping of human chromosome 5 microsatellite DNA polymorphisms.

Authors:  J L Weber; M H Polymeropoulos; P E May; A E Kwitek; H Xiao; J D McPherson; J J Wasmuth
Journal:  Genomics       Date:  1991-11       Impact factor: 5.736

6.  The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study.

Authors:  D T Felson; J J Anderson; A Naimark; W Kannel; R F Meenan
Journal:  J Rheumatol       Date:  1989-09       Impact factor: 4.666

7.  Hereditary chondrocalcinosis in a Tunisian family.

Authors:  M Hamza; N Meddeb; T Bardin
Journal:  Clin Exp Rheumatol       Date:  1992 Jan-Feb       Impact factor: 4.473

8.  Hereditary chondrocalcinosis in an Ashkenazi Jewish family.

Authors:  G Eshel; A Gulik; N Halperin; E Avrahami; H R Schumacher; D J McCarty; D Caspi
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

9.  Familial articular chondrocalcinosis in Spain.

Authors:  A Balsa; E Martín-Mola; T Gonzalez; A Cruz; S Ojeda; J Gijón-Baños
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

10.  Familial chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition in English families.

Authors:  M Doherty; E Hamilton; J Henderson; H Misra; J Dixey
Journal:  Br J Rheumatol       Date:  1991-02
View more
  12 in total

Review 1.  Familial and clinical aspects of calcium pyrophosphate deposition disease.

Authors:  A J Reginato; E Tamesis; P Netter
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

2.  Novel ANKH amino terminus mutation (Pro5Ser) associated with early-onset calcium pyrophosphate disease with associated phosphaturia.

Authors:  Barry L Gruber; Ana Rita Couto; Jácome Bruges Armas; Matthew A Brown; Kathleen Finzel; Robert A Terkeltaub
Journal:  J Clin Rheumatol       Date:  2012-06       Impact factor: 3.517

3.  Investigating ANKH and ENPP1 in Slovakian families with chondrocalcinosis.

Authors:  Ana Rita Couto; Yun Zhang; Andrew Timms; Jacome Bruges-Armas; Jorge Sequeiros; Matthew A Brown
Journal:  Rheumatol Int       Date:  2011-08-03       Impact factor: 2.631

4.  Mutations in ANKH cause chondrocalcinosis.

Authors:  Adrian Pendleton; Michelle D Johnson; Anne Hughes; Kyle A Gurley; Andrew M Ho; Michael Doherty; Josh Dixey; Pierre Gillet; Damien Loeuille; Rodney McGrath; Antonio Reginato; Rita Shiang; Gary Wright; Patrick Netter; Charlene Williams; David M Kingsley
Journal:  Am J Hum Genet       Date:  2002-09-20       Impact factor: 11.025

5.  Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH.

Authors:  Charlene J Williams; Yun Zhang; Andrew Timms; Gina Bonavita; Francisco Caeiro; John Broxholme; Jonathan Cuthbertson; Yvonne Jones; Raul Marchegiani; Antonio Reginato; R Graham G Russell; B Paul Wordsworth; Andrew J Carr; Matthew A Brown
Journal:  Am J Hum Genet       Date:  2002-09-17       Impact factor: 11.025

Review 6.  Genetics and mechanisms of crystal deposition in calcium pyrophosphate deposition disease.

Authors:  Florence W L Tsui
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 7.  Pathophysiology of articular chondrocalcinosis--role of ANKH.

Authors:  Abhishek Abhishek; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2010-11-23       Impact factor: 20.543

Review 8.  Pathogenesis of calcium pyrophosphate crystal deposition disease.

Authors:  A K Rosenthal
Journal:  Curr Rheumatol Rep       Date:  2001-02       Impact factor: 4.592

Review 9.  Calcium pyrophosphate dihydrate and hydroxyapatite crystal deposition in the joint: new developments relevant to the clinician.

Authors:  Salih Pay; Robert Terkeltaub
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

10.  The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis.

Authors:  Judith Leyens; Tim Th A Bender; Martin Mücke; Christiane Stieber; Dmitrij Kravchenko; Christian Dernbach; Matthias F Seidel
Journal:  Orphanet J Rare Dis       Date:  2021-07-22       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.